InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Zoetis

ZTS Clue Score72
United States Fiscal year ends December CIK 0001555280
$74.81 +2.37% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $74.81 −62.15% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueNet income
Fiscal year 2016Revenue4.89Net income0.82EPS, diluted1.65Fiscal year 2017Revenue5.31 +8.6%Net income0.86 +5.2%EPS, diluted1.75 +6.1%Fiscal year 2018Revenue5.83 +9.8%Net income1.43 +65.3%EPS, diluted2.93 +67.4%Fiscal year 2019Revenue6.26 +7.5%Net income1.50 +5.0%EPS, diluted3.11 +6.1%Fiscal year 2020Revenue6.68 +6.6%Net income1.64 +9.2%EPS, diluted3.42 +10.0%Fiscal year 2021Revenue7.78 +16.5%Net income2.04 +24.4%EPS, diluted4.27 +24.9%Fiscal year 2022Revenue8.08 +3.9%Net income2.11 +3.8%EPS, diluted4.49 +5.2%Fiscal year 2023Revenue8.54 +5.7%Net income2.34 +10.9%EPS, diluted5.07 +12.9%Fiscal year 2024Revenue9.26 +8.3%Net income2.49 +6.1%EPS, diluted5.47 +7.9%Fiscal year 2025Revenue9.47 +2.3%Net income2.67 +7.5%EPS, diluted6.02 +10.1%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 4.89 5.31 5.83 6.26 6.68 7.78 8.08 8.54 9.26 9.47
Growth +8.6% +9.8% +7.5% +6.6% +16.5% +3.9% +5.7% +8.3% +2.3%
Net income 0.82 0.86 1.43 1.50 1.64 2.04 2.11 2.34 2.49 2.67
Growth +5.2% +65.3% +5.0% +9.2% +24.4% +3.8% +10.9% +6.1% +7.5%
EPS, diluted 1.65 1.75 2.93 3.11 3.42 4.27 4.49 5.07 5.47 6.02
Growth +6.1% +67.4% +6.1% +10.0% +24.9% +5.2% +12.9% +7.9% +10.1%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Net margin
Fiscal year 2016Net margin16.8%Free cash flow margin10.2%Fiscal year 2017Net margin16.3%Free cash flow margin21.1%Fiscal year 2018Net margin24.5%Free cash flow margin24.9%Fiscal year 2019Net margin24.0%Free cash flow margin21.3%Fiscal year 2020Net margin24.5%Free cash flow margin25.1%Fiscal year 2021Net margin26.2%Free cash flow margin22.3%Fiscal year 2022Net margin26.2%Free cash flow margin16.4%Fiscal year 2023Net margin27.4%Free cash flow margin19.0%Fiscal year 2024Net margin26.9%Free cash flow margin24.8%Fiscal year 2025Net margin28.2%Free cash flow margin24.1%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net margin 16.8% 16.3% 24.5% 24.0% 24.5% 26.2% 26.2% 27.4% 26.9% 28.2%
Free cash flow margin 10.2% 21.1% 24.9% 21.3% 25.1% 22.3% 16.4% 19.0% 24.8% 24.1%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow0.71Capital expenditure−0.22Free cash flow0.50Buybacks−0.30Fiscal year 2017Operating cash flow1.35Capital expenditure−0.22Free cash flow1.12 +125.8%Buybacks−0.50Fiscal year 2018Operating cash flow1.79Capital expenditure−0.34Free cash flow1.45 +29.4%Buybacks−0.70Fiscal year 2019Operating cash flow1.80Capital expenditure−0.46Free cash flow1.34 −8.1%Buybacks−0.63Fiscal year 2020Operating cash flow2.13Capital expenditure−0.45Free cash flow1.67 +25.3%Buybacks−0.25Fiscal year 2021Operating cash flow2.21Capital expenditure−0.48Free cash flow1.74 +3.8%Buybacks−0.74Fiscal year 2022Operating cash flow1.91Capital expenditure−0.59Free cash flow1.33 −23.6%Buybacks−1.59Fiscal year 2023Operating cash flow2.35Capital expenditure−0.73Free cash flow1.62 +22.2%Buybacks−1.09Fiscal year 2024Operating cash flow2.95Capital expenditure−0.66Free cash flow2.30 +41.8%Buybacks−1.86Fiscal year 2025Operating cash flow2.90Capital expenditure−0.62Free cash flow2.28 −0.7%Buybacks−3.24
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 0.71 1.35 1.79 1.80 2.13 2.21 1.91 2.35 2.95 2.90
Capital expenditure −0.22 −0.22 −0.34 −0.46 −0.45 −0.48 −0.59 −0.73 −0.66 −0.62
Free cash flow 0.50 1.12 1.45 1.34 1.67 1.74 1.33 1.62 2.30 2.28
Growth +125.8% +29.4% −8.1% +25.3% +3.8% −23.6% +22.2% +41.8% −0.7%
Buybacks −0.30 −0.50 −0.70 −0.63 −0.25 −0.74 −1.59 −1.09 −1.86 −3.24

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash0.73Total debt4.47Net cash (debt)−3.74Shareholders’ equity1.49Debt to equity3.00Fiscal year 2017Cash1.56Total debt4.95Net cash (debt)−3.39Shareholders’ equity1.77Debt to equity2.80Fiscal year 2018Cash1.60Total debt6.44Net cash (debt)−4.84Shareholders’ equity2.19Debt to equity2.95Fiscal year 2019Cash1.93Total debt6.45Net cash (debt)−4.51Shareholders’ equity2.71Debt to equity2.38Fiscal year 2020Cash3.60Total debt7.20Net cash (debt)−3.59Shareholders’ equity3.77Debt to equity1.91Fiscal year 2021Cash3.49Total debt6.59Net cash (debt)−3.11Shareholders’ equity4.54Debt to equity1.45Fiscal year 2022Cash3.58Total debt7.90Net cash (debt)−4.32Shareholders’ equity4.41Debt to equity1.79Fiscal year 2023Cash2.04Total debt6.56Net cash (debt)−4.52Shareholders’ equity5.00Debt to equity1.31Fiscal year 2024Cash1.99Total debt6.57Net cash (debt)−4.58Shareholders’ equity4.77Debt to equity1.38Fiscal year 2025Cash2.45Total debt9.04Net cash (debt)−6.59Shareholders’ equity3.33Debt to equity2.71
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 0.73 1.56 1.60 1.93 3.60 3.49 3.58 2.04 1.99 2.45
Total debt 4.47 4.95 6.44 6.45 7.20 6.59 7.90 6.56 6.57 9.04
Net cash (debt) −3.74 −3.39 −4.84 −4.51 −3.59 −3.11 −4.32 −4.52 −4.58 −6.59
Shareholders’ equity 1.49 1.77 2.19 2.71 3.77 4.54 4.41 5.00 4.77 3.33
Debt to equity 3.00 2.80 2.95 2.38 1.91 1.45 1.79 1.31 1.38 2.71

In billions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In billions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Operations
0.71 1.35 1.79 1.80 2.13 2.21 1.91 2.35 2.95 2.90
Growth +88.8% +33.0% +0.3% +18.4% +4.1% −13.6% +23.1% +25.5% −1.7%
0.24 0.24 0.31 0.41 0.44 0.45 0.47 0.49 0.50 0.49
Investment
−0.22 −0.22 −0.34 −0.46 −0.45 −0.48 −0.59 −0.73 −0.66 −0.62
calc 0.50 1.12 1.45 1.34 1.67 1.74 1.33 1.62 2.30 2.28
Growth +125.8% +29.4% −8.1% +25.3% +3.8% −23.6% +22.2% +41.8% −0.7%
calc 1.00 2.28 2.98 2.77 3.50 3.64 2.82 3.51 5.05 5.14
−0.21 −0.27 −2.26 −0.50 −0.57 −0.46 −0.88 −0.78 −0.32 −0.75
Financing
−0.90 −0.25 0.53 −0.95 0.12 −1.86 −0.90 −3.11 −2.66 −1.87
−0.30 −0.50 −0.70 −0.63 −0.25 −0.74 −1.59 −1.09 −1.86 −3.24

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative.